| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
32,332 |
20,709 |
$1.69M |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
1,198 |
1,173 |
$795K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,568 |
14,103 |
$645K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
5,236 |
5,065 |
$526K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,667 |
4,330 |
$429K |
| 76801 |
|
3,773 |
3,474 |
$360K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
4,233 |
2,047 |
$294K |
| 59430 |
|
2,239 |
2,179 |
$235K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,574 |
4,394 |
$226K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
10,498 |
10,102 |
$195K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,878 |
6,575 |
$185K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,884 |
6,578 |
$185K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,132 |
2,046 |
$175K |
| 81002 |
|
44,212 |
27,548 |
$126K |
| 86780 |
|
9,989 |
9,591 |
$102K |
| 87653 |
|
3,011 |
2,948 |
$85K |
| 87800 |
|
2,301 |
2,204 |
$81K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
990 |
958 |
$75K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,411 |
11,700 |
$74K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,107 |
1,066 |
$68K |
| 86850 |
|
8,030 |
7,738 |
$61K |
| 90715 |
|
1,419 |
1,386 |
$60K |
| 76830 |
Ultrasound, transvaginal |
515 |
506 |
$49K |
| 81025 |
|
7,387 |
6,705 |
$48K |
| 87340 |
|
5,848 |
5,627 |
$47K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,297 |
3,155 |
$44K |
| 86762 |
|
3,726 |
3,578 |
$42K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,303 |
1,254 |
$33K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,065 |
4,838 |
$32K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,421 |
2,287 |
$25K |
| 99219 |
|
236 |
227 |
$21K |
| 80081 |
|
291 |
280 |
$20K |
| 86900 |
|
8,095 |
7,797 |
$19K |
| 86901 |
|
8,092 |
7,794 |
$19K |
| 82950 |
|
3,846 |
3,743 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
235 |
229 |
$13K |
| 59514 |
|
15 |
15 |
$12K |
| 90686 |
|
588 |
574 |
$11K |
| 96136 |
|
2,726 |
2,614 |
$11K |
| 81000 |
|
4,597 |
4,411 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,224 |
1,180 |
$9K |
| 54150 |
|
67 |
66 |
$6K |
| 84702 |
|
398 |
257 |
$5K |
| 86592 |
|
532 |
518 |
$2K |
| 82951 |
|
162 |
161 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
12 |
12 |
$2K |
| 84144 |
|
91 |
69 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
73 |
57 |
$851.96 |
| 82952 |
|
146 |
145 |
$440.71 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
20 |
20 |
$167.04 |
| 0500F |
|
1,233 |
1,191 |
$0.00 |
| 0503F |
|
1,031 |
1,004 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,049 |
1,022 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
826 |
710 |
$0.00 |